Listing 1 - 4 of 4 |
Sort by
|
Choose an application
This Special Issue contains review articles focusing on several lymphoma entities included in the current WHO classification. The aim of the book is to guide the readers in understanding the evolution of lymphoma classification. The clinicopathological entities described in this issue have been analyzed through the molecular mechanisms involved in their pathogenesis.
Medicine --- lymphomas in PLWH --- KSHV/HHV8 --- EBV --- lymphoma classification --- management --- cART --- HLX --- HOXB9 --- NFIB --- PBX1 --- STAT3 --- TLX2 --- autoimmune hemolytic anemia --- cold agglutinin --- B-cell lymphoproliferative disorder --- lymphomagenesis --- methylation --- histone modification --- indolent --- T-cell --- NK-cell --- lymphoproliferative disorder --- gastrointestinal tract --- genetics --- cell of origin --- T follicular helper cells --- TFH lymphoma --- angioimmunoblastic T-cell lymphoma --- follicular T-cell lymphoma --- peripheral T-cell lymphoma of T-follicular helper immunophenotype --- peripheral T-cell lymphoma --- primary cutaneous B-cell lymphoma --- primary cutaneous marginal zone B-cell lymphoma --- primary cutaneous follicle centre lymphoma --- primary cutaneous diffuse large B-cell lymphoma, leg-type --- primary cutaneous diffuse large B-cell lymphoma, not otherwise specified --- intravascular B-cell lymphoma --- EBV+ mucocutaneous ulcer --- Burkitt lymphoma --- epidemiology --- Plasmodium falciparum --- Epstein Barr virus --- registry studies --- multimodal cancer --- non-Hodgkin lymphoma --- HIV/AIDS --- follicular lymphoma --- in situ follicular neoplasia --- FL transformation --- FL in young patients --- diffuse large B-cell lymphoma NOS --- high grade B-cell lymphoma --- lymphoma --- gene expression profiling --- tumor microenvironment --- diagnostics --- centrocytic lymphoma --- intermediate lymphocytic lymphoma --- Jaffe --- mantle cell lymphoma --- mantle zone lymphoma --- cyclin D1 --- lymphomas --- people living with HIV --- tumor prevention in people living with HIV --- KSHV --- BCL2 rearrangement --- genetic alterations --- histological transformation --- targeted therapies --- transformed follicular lymphoma --- lymphoproliferative neoplasms of uncertain biological significance --- monoclonal B-cell lymphocytosis --- “in situ” follicular neoplasia --- “in situ” mantle cell neoplasia --- atypical germinal centers --- large B-cell lymphoma with IRF4 rearrangement --- “in situ” high-grade B lymphomas --- Hodgkin lymphoma
Choose an application
This reprint contains 11 chapters on a wide range of subjects related to the impacts of different types of epidemics on our ability to practice personalized medicine. Together, these chapters provide a broad overview with many different examples of epidemics. The personalization of medicine is present both despite and because of epidemics. Many more examples are possible, but this reprint offers a primary overview emphasizing the widely spread relevance of the topic.
Medicine --- Pharmacology --- diabetes mellitus --- cluster analyses --- risk factors --- micro- and macrovascular disease --- hyperuricemia --- sex --- renal progression --- chronic kidney disease --- disability --- children --- oral health --- caries --- dental treatment --- personalized medicine --- precision medicine --- Covid-19 --- SARS CoV2 --- epidemiology --- host genetics --- viral genome --- early diagnosis --- type 1 diabetes mellitus --- COVID-19 --- epidemics --- diabetic ketoacidosis --- hypertension and type 2 diabetes mellitus comorbidity --- IgG --- N-glycosylation --- biomarkers --- tongue pressure --- aging --- community --- elderly --- tuberculosis --- pulmonary function --- respiratory symptoms --- quality of life --- hepatitis C virus --- diffuse large B-cell lymphoma --- survival --- fibrosis --- performance status --- liver toxicity --- abdominal adiposity --- adolescents --- blood pressure --- obesity --- Jordan --- boys --- lung cancer screening --- smoking --- willingness to screen --- education --- n/a
Choose an application
This reprint contains 11 chapters on a wide range of subjects related to the impacts of different types of epidemics on our ability to practice personalized medicine. Together, these chapters provide a broad overview with many different examples of epidemics. The personalization of medicine is present both despite and because of epidemics. Many more examples are possible, but this reprint offers a primary overview emphasizing the widely spread relevance of the topic.
diabetes mellitus --- cluster analyses --- risk factors --- micro- and macrovascular disease --- hyperuricemia --- sex --- renal progression --- chronic kidney disease --- disability --- children --- oral health --- caries --- dental treatment --- personalized medicine --- precision medicine --- Covid-19 --- SARS CoV2 --- epidemiology --- host genetics --- viral genome --- early diagnosis --- type 1 diabetes mellitus --- COVID-19 --- epidemics --- diabetic ketoacidosis --- hypertension and type 2 diabetes mellitus comorbidity --- IgG --- N-glycosylation --- biomarkers --- tongue pressure --- aging --- community --- elderly --- tuberculosis --- pulmonary function --- respiratory symptoms --- quality of life --- hepatitis C virus --- diffuse large B-cell lymphoma --- survival --- fibrosis --- performance status --- liver toxicity --- abdominal adiposity --- adolescents --- blood pressure --- obesity --- Jordan --- boys --- lung cancer screening --- smoking --- willingness to screen --- education --- n/a
Choose an application
This reprint contains 11 chapters on a wide range of subjects related to the impacts of different types of epidemics on our ability to practice personalized medicine. Together, these chapters provide a broad overview with many different examples of epidemics. The personalization of medicine is present both despite and because of epidemics. Many more examples are possible, but this reprint offers a primary overview emphasizing the widely spread relevance of the topic.
Medicine --- Pharmacology --- diabetes mellitus --- cluster analyses --- risk factors --- micro- and macrovascular disease --- hyperuricemia --- sex --- renal progression --- chronic kidney disease --- disability --- children --- oral health --- caries --- dental treatment --- personalized medicine --- precision medicine --- Covid-19 --- SARS CoV2 --- epidemiology --- host genetics --- viral genome --- early diagnosis --- type 1 diabetes mellitus --- COVID-19 --- epidemics --- diabetic ketoacidosis --- hypertension and type 2 diabetes mellitus comorbidity --- IgG --- N-glycosylation --- biomarkers --- tongue pressure --- aging --- community --- elderly --- tuberculosis --- pulmonary function --- respiratory symptoms --- quality of life --- hepatitis C virus --- diffuse large B-cell lymphoma --- survival --- fibrosis --- performance status --- liver toxicity --- abdominal adiposity --- adolescents --- blood pressure --- obesity --- Jordan --- boys --- lung cancer screening --- smoking --- willingness to screen --- education --- diabetes mellitus --- cluster analyses --- risk factors --- micro- and macrovascular disease --- hyperuricemia --- sex --- renal progression --- chronic kidney disease --- disability --- children --- oral health --- caries --- dental treatment --- personalized medicine --- precision medicine --- Covid-19 --- SARS CoV2 --- epidemiology --- host genetics --- viral genome --- early diagnosis --- type 1 diabetes mellitus --- COVID-19 --- epidemics --- diabetic ketoacidosis --- hypertension and type 2 diabetes mellitus comorbidity --- IgG --- N-glycosylation --- biomarkers --- tongue pressure --- aging --- community --- elderly --- tuberculosis --- pulmonary function --- respiratory symptoms --- quality of life --- hepatitis C virus --- diffuse large B-cell lymphoma --- survival --- fibrosis --- performance status --- liver toxicity --- abdominal adiposity --- adolescents --- blood pressure --- obesity --- Jordan --- boys --- lung cancer screening --- smoking --- willingness to screen --- education
Listing 1 - 4 of 4 |
Sort by
|